{"id":"NCT03207009","sponsor":"bluebird bio","briefTitle":"A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia","officialTitle":"A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects With Transfusion-dependent β-Thalassemia by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector in Subjects ≤50 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-06-08","primaryCompletion":"2022-11-15","completion":"2022-11-15","firstPosted":"2017-07-02","resultsPosted":"2023-12-29","lastUpdate":"2024-03-07"},"enrollment":19,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Beta-Thalassemia"],"interventions":[{"type":"GENETIC","name":"LentiGlobin BB305 Drug Product","otherNames":["betibeglogene autotemcel"]}],"arms":[{"label":"LentiGlobin BB305 Drug Product","type":"EXPERIMENTAL"}],"summary":"This is a single-arm, multi-site, single-dose, Phase 3 study in approximately 18 participants less than or equal to (\\<=) 50 years of age with transfusion-dependent β-thalassemia (TDT), who have a β0/β0, β0/IVS-I-110, or IVS-I-110/IVS-I-110 genotype. The study will evaluate the efficacy and safety of autologous hematopoietic stem cell transplantation (HSCT) using LentiGlobin BB305 Drug Product.","primaryOutcome":{"measure":"Percentage of Participants Who Have Achieved Transfusion Independence (TI)","timeFrame":"From 12 to 24 months post-transplant","effectByArm":[{"arm":"LentiGlobin BB305 Drug Product","deltaMin":88.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"0 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":9,"countries":["United States","France","Germany","Greece","Italy","United Kingdom"]},"refs":{"pmids":["39527960"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":19},"commonTop":["Thrombocytopenia","Neutropenia","Anaemia","Vomiting","Alopecia"]}}